BPY2

Q-omics provides the consensus-scored BPY2 profile across patient tissues and cancer cell-line models. BPY2 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, BPY2 RNA expression shows 52 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight BLCA, and LAML as cancer lineages where BPY2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes BPY2 survival associations across molecular data types. BPY2 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

BPY2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	BLCA (117)	view →

This table ranks reproducible BPY2 RNA expression–survival associations across cancer types. High BPY2 expression shows unfavorable associations in BLCA and LIHC. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for BPY2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.141	0.710	<.001	117	view →
LIHC	DFS	Tertile	All	0.038	0.553	<.001	36	view →

Pink = unfavorable, green = favorable. all 2 lineages →

BPY2-BLCA (OS)

Explore this curve interactively →